Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Q3 2024 Management View Revenue for Q3 FY2024 increased 16.6% year-on-year to ¥1,367.6 billion, driven by growth in oncology ...

Japanese drugmaker Daiichi Sankyo has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective April 1, 2025.

Singer Linda Nolan was brought to her funeral in a pink sparkly coffin as a large crowd of family and friends gathered in ...

Linda Nolan's funeral will be held today as her family and friends celebrate her "remarkable life". Members of the public are welcome to pay their respects at the church for the service at 10.30am on ...

The Nolans star, known by many TV fans for her Celebrity Big Brother appearance and by others as a theatre performer, was ...

Actor Shane Richie was among the first people to arrive for the funeral of Linda Nolan in Blackpool. The service at St Paul’s ...

Nolan married her husband of more than two decades, Brian Hudson, in the Blackpool church, and said goodbye to him there ...

For years, Linda Nolan was open about the realities of living with incurable cancer, and during her final days, made sure to document every moment, including her last Christmas ...

Enhertu is already approved for patients with HR+, HER2-low breast cancer after endocrine therapy based on the DESTINY-Breast04 trial data, but adding the DESTINY-Breast06 data to the label ...